The presumptive new CDC director, Dave Weldon, is a known vaccine safety skeptic. In contrast, the FDA choice — Johns Hopkins ...

BridgeBio Pharma Inc. jumped the most in 16 months after its drug got US regulators’ nod to treat a rare, deadly form of ...

The Food and Drug Administration (FDA) has expanded the list of medicines exempted from value-added tax (VAT) to ensure ...

The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to ...

(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...

(Reuters) -Cassava Sciences said on Monday it will stop all trials of its Alzheimer's disease drug after it failed a ...

(Nasdaq:LEXX)(Nasdaq:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms is pleased to announce that dosing has been completed for human pilot study #3 (the 'Study') ...

The sober living homes has its defenders who say those who are critical ‘didn’t do what they were supposed to do or didn’t ...

Researchers from John Hopkins linked a common drug to a loss of bone tissue - a condition that with age, can be associated with bone fracture, limited mobility and death ...

FDA approves BridgeBio's Attruby for ATTR-CM, the first treatment labeled for near-complete stabilization of TTR in adults.

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...